Two Giants Dominate IHE, Making It Riskier Than It Looks
As of March 2026, the iShares U.S. Pharmaceuticals ETF is heavily keyed to two drugmakers, exposing investors to outs...
Learn about retirement plans that might be better than a 401k. Enhance your retirement strategy with informed choices.
27,827 articlesAs of March 2026, the iShares U.S. Pharmaceuticals ETF is heavily keyed to two drugmakers, exposing investors to outs...
NVIDIA still leads the AI chip race, but investors are spreading bets downstream to adjacent AI opportunities as the ...
Federal investigators say UCLA's David Geffen School of Medicine used race in admissions in ways that violated civil ...
Soccer has overtaken baseball in U.S. popularity, a shift that could reshape family entertainment budgets and the val...
A new AI-driven forecast puts Solana on a trajectory to smash expectations by late 2026, driven by on-chain adoption ...
ZachXBT alleges insider control as LAB token scrutiny rises amid an investigation into AI Terminal's $6 billion FDV p...
Mortgage rates have climbed to yearly highs as the 10-year yield advances, but housing demand remains positive due to...
Ethereum retreats toward the $2,100 level as macro factors weigh on the market, setting up a test of demand for one o...
A hedge fund warns that a toxic cocktail of rising inflation and undercompensated bond yields could push the S&P 500 ...
A private market deal around a smartphone rewards model is near closing, riding momentum from Deloitte’s fastest-grow...
A single platform now powers a large share of global digital infrastructure, triggering merger chatter and forcing in...
AI verification flags a missing proof in a landmark 1976 economic theorem, risking a rethink of models relied upon in...